American Journal of Obstetrics & Gynecology
Volume 194, Issue 3 , Pages 821-827 , March 2006

Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin

  • Fawaz Alkazaleh, MD

      Affiliations

    • Departments of Obstetrics and Gynaecology (Maternal-Fetal Medicine Division Placenta Clinic)
    • ,
  • Vandana Chaddha, MD

      Affiliations

    • Departments of Obstetrics and Gynaecology (Maternal-Fetal Medicine Division Placenta Clinic)
    • ,
  • Sandra Viero, MD

      Affiliations

    • Pathology and Laboratory Medicine
    • ,
  • Aasim Malik, MB

      Affiliations

    • Departments of Obstetrics and Gynaecology (Maternal-Fetal Medicine Division Placenta Clinic)
    • ,
  • Colleen Anastasiades, RDMS

      Affiliations

    • Departments of Obstetrics and Gynaecology (Maternal-Fetal Medicine Division Placenta Clinic)
    • ,
  • Hana Sroka, MSc

      Affiliations

    • Medical Genetics
    • ,
  • David Chitayat, MD

      Affiliations

    • Departments of Obstetrics and Gynaecology (Maternal-Fetal Medicine Division Placenta Clinic)
    • Medical Genetics
    • ,
  • Ants Toi, MD

      Affiliations

    • Departments of Obstetrics and Gynaecology (Maternal-Fetal Medicine Division Placenta Clinic)
    • Medical Imaging, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Rory C. Windrim, MSc, MD

      Affiliations

    • Departments of Obstetrics and Gynaecology (Maternal-Fetal Medicine Division Placenta Clinic)
    • ,
  • John C. Kingdom, MD

      Affiliations

    • Departments of Obstetrics and Gynaecology (Maternal-Fetal Medicine Division Placenta Clinic)
    • Pathology and Laboratory Medicine
    • Medical Imaging, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada

Received 17 February 2005 ,Revised 1 September 2005 ,Accepted 29 September 2005.

References 

  1. Rankin J, Glinianaia S, Brown R, Renwick M. The changing prevalence of neural tube defects: a population-based study in the north of England, 1984-96. Northern Congenital Abnormality Survey Steering Group. Paediatr Perinat Epidemiol. 2000;14:104–110
  2. Khoshnood B, De Vigan C, Vodovar V, Goujard J, Goffinet F. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. BJOG. 2004;111:485–490
  3. Waller DK, Lustig LS, Cunningham GC, Golbus MS, Hook EB. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med. 1991;325:6–10
  4. Lepage N, Chitayat D, Kingdom J, Huang T. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol. 2003;188:1354–1359
  5. Chitayat D, Farrell SA, Huang T, Meier C, Wyatt PR, Summers AM. Double-positive maternal serum screening results for down syndrome and open neural tube defects: an indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes. Am J Obstet Gynecol. 2002;187:758–763
  6. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, et al. for the FASTER Trial Research Consortium Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol. 2005;106:260–267
  7. Huang T, Owolabi T, Summers AM, Meier C, Wyatt PR. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening. Am J Obstet Gynecol. 2005;193:395–403
  8. Viero S, Chaddha V, Alkazaleh F, Simchen MJ, Malik A, Kelly E, et al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta. 2004;25:735–741
  9. Konchak PS, Bernstein IM, Capeless EL. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. Am J Obstet Gynecol. 1995;173:1115–1119
  10. Bromley B, Frigoletto FD, Harlow BL, Pauker S, Benacerraf BR. The role of Doppler velocimetry in the structurally normal second-trimester fetus with elevated levels of maternal serum alpha-fetoprotein. Ultrasound Obstet Gynecol. 1994;4:377–380
  11. Palacio M, Jauniaux E, Kingdom J, Dell E, Sheldrake A, Rodeck CH. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin. Ultrasound Obstet Gynecol. 1999;13:58–62
  12. Jauniaux E, Moscoso G, Campbell S, Gibb D, Driver M, Nicolaides KH. Correlation of ultrasound and pathologic findings of placental anomalies in pregnancies with elevated maternal serum alpha-fetoprotein. Eur J Obstet Gynecol Reprod Biol. 1990;37:219–230
  13. Williams MA, Hickok DE, Zingheim RW, Luthy DA, Kimelman J, Nyberg DA, et al. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol. 1992;167:1032–1037
  14. Alkazaleh F, Viero S, Walker M, Walker M, Smith G, Laskin C, et al. Ultrasound diagnosis of severe thrombotic placental damage in the second trimester. Ultrasound Obstet Gynecol. 2004;23:472–476
  15. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol. 2000;96:559–564
  16. Duley L, Henderson-Smart DJ, Knight M, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2004;(1):CD004659
  17. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1999;354:810–816
  18. Simchen MJ, Alkazaleh F, Adamson SL, Windrim R, Telford J, Beyene J, et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol. 2004;190:296–304
  19. ACOG technical bulletin . Hypertension in pregnancy. Number 219–January 1996 (replaces no 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1996;53:175–183
  20. Huppertz B, Kingdom JCP. Apoptosis in the trophoblast—role of apoptosis in placental morphogenesis. J Soc Gyn Invest. 2004;11:353–362
  21. Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P, Rath W, et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest. 2001;81:1143–1152
  22. Smith GC, Crossley JA, Aitken DA, Pell JP, Cameron AD, Connor JM, et al. First-trimester placentation and the risk of antepartum stillbirth. JAMA. 2004;292:2249–2254
  23. Yu CK, Papageorghiou AT, Parra M, Palma DR, Nicolaides KH. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol. 2003;22:233–239
  24. Gris JC, Mercier E, Quere I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004;103:3695–3699
  25. Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther. 2005;20:48–53

 Supported by Rose Torno Chair in Obstetrics and Gynaecology (to J. K.).Reprints not available from the authors.

PII: S0002-9378(05)01500-0

doi: 10.1016/j.ajog.2005.09.010

American Journal of Obstetrics & Gynecology
Volume 194, Issue 3 , Pages 821-827 , March 2006

Article Tools